
ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript
ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.38. Operator: Good morning, ladies and gentlemen, and welcome to ADC Therapeutics’ …